NEC
19.3.2021 03:02:08 CET | Business Wire | Press release
NEC Corporation (NEC; TOKYO: 6701) and its subsidiary OCC Corporation announced today that they have completed full qualification of subsea repeaters and optical cable containing up to 24 fiber pairs (FPs) (48 fibers). This is a 50% improvement in fiber count over the 16 fiber pair systems generally available today. This development allows cable owners worldwide to construct subsea telecom cables with superior traffic capacity while reducing the cost per bit of the wet plant. This approach is fully in line with SDM (Space Division Multiplexing) system architectures. NEC’s 24 FP solution not only provides more flexibility to operate in the subsea fiber pair market, it also enables better connectivity in high-density subsea branches.
NEC achieved this milestone with minor modifications to its proven repeater and cable designs. Keeping NEC’s quadruple pump redundancy in the repeater (established more than 10 years ago) and maintaining OCC’s outstanding cabling performance has resulted in cabled attenuations lower than 0.150dB/km. Low attenuation is critical to achieve large spectral efficiency as well as lower power consumption.
“As global demands for capacity and FP flexibility continue to soar, NEC is committed to helping our customers to build up their subsea networks with large spectral efficiency, lower power consumption and large-scale subsea connectivity,” said Yoshihisa Inada, Deputy General Manager and Head of Subsea Technology Development at NEC’s Submarine Network Division. “We continue to evaluate multiple technical options to further increase capacity and reduce the cost/bit of the networks.”
OCC’s 24 fiber pair cable can be manufactured using a wide range of existing optical fibers, according to the needs of each new cable system. Each fiber can be visually identified using a field-proven combination of ring marking and conventional fiber coloring, first introduced in 2013. Furthermore, in OCC cable, the fiber’s transmission performance is completely unaffected, either by the fiber marking or cabling processes.
“We have concluded that the use of our fibers in OCC’s 24 pair cable results in a cabled attenuation matching the nominal value. We are confident that our ultra-low-loss fibers can contribute to achieve large capacity, high spectral efficiency and low power consumption in transoceanic networks,” said Dr. Masashi Onishi, General Manager at Optical Fiber and Cable division of Sumitomo Electric Industries Ltd.
“To support growing bandwidth, next generation subsea systems will offer Petabit-scale transmission. To achieve the required performance, cabling processes must capture the advantaged optical attenuation and large effective area of our ultra-low-loss fibers. OCC’s cabling process for 24 fiber pairs works with our high quality fiber to meet the challenge,” said Dr. Bernhard Deutsch, VP & GM, Optical Fiber & Cable, Corning Incorporated.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210318006059/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
